Answers are grounded in this paper and cite their sources.
Autoimmune myelofibrosis (AIMF) is considered as an infrequent cause of bone marrow fibrosis (BMF) and a rare complication of systemic lupus erythematosus (SLE).Due to its rarity, it is mistakenly diagnosed as primary myelofibrosis (MF).We describe the clinicopathologic features of a secondary form of AIMF in a 33year-old female patient with an undiagnosed SLE which presented with acute bicytopenia.Absence of splenomegaly, leukopenia, anemia, BMF (grade MF-1), and presence of autoantibodies were some of noticeable features.Treatment with corticosteroid led to complete regeneration of the bone marrow and subsequently to an improved hematological status.Six-month follow-up showed that the patient was in good clinical condition.Identification of AIMF is a diagnostic challenge and pitfall and it is actually a diagnosis of exclusion.It could be the first and only presenting feature of SLE and results in hematologic disturbances.So, we should consider SLE-associated AIMF in the differential diagnosis of pancytopenia.
No takes yet. Share an insight, caveat, or question.
Rajabi‐Moghaddam et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: